ZN-c3 in Adult Participants With BRAF mutant Metastatic Colorectal Cancer
1 月 9, 2024
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer ( SEAMARK )
